Cochrane Summariesbeta

Independent high-quality evidence for health care decision making

The effects of anticholinergic drugs in the treatment of bronchiectasis

Lasserson TJ, Holt K, Evans DJ, Milan SJ, Greenstone M
Published Online: 
June 15, 2011

Bronchiectasis is a chronic respiratory disease. People with the condition experience difficulty in clearing mucus from their lungs, leaving them prone to infections. Atrovent and other anticholinergic agents are bronchodilators which could help with opening up the airways in people with bronchiectasis. We looked for randomised studies addressing this question but we could not identify any evidence for or against the use of anticholinergic drugs in the treatment of bronchiectasis.

Find the research
Health topics: